Daily Versus Thrice-Weekly Interferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Persons: A Multicenter Randomized Controlled Trial

Mark S. Sulkowski, Franco Felizarta, Cheryl Smith, Jidah Slim, Ruth Berggren, Russell Goodman, Lisa Ball, Mandana Khalili, Douglas T. Dieterich

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint Dive into the research topics of 'Daily Versus Thrice-Weekly Interferon Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in HIV-Infected Persons: A Multicenter Randomized Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences